Literature DB >> 7364813

Dupuytren's contracture. An electron microscopic, biochemical, and clinical correlative study.

R H Gelberman, D Amiel, R M Rudolph, R M Vance.   

Abstract

Fascial specimens were obtained from twenty-four patients treated operatively for Dupuytren's contracture. The nodules and cords were examined by electron microscopic and biochemical techniques. The clinical course and response to operative treatment were then correlated with the tissue findings. Electron microscopic analysis revealed myofibroblasts in the nodules of seven of twenty-four patients. Fibroblasts containing prominent microtubules were found in ten patients. The fascia contained type-III collagen, increased amounts of collagen per unit of dry weight, and an increase in reducible cross-links of collagen. While the nodules were noted to contain a greater increase in reducible cross-links than the cords, there was little variation in the biochemical findings from patient to patient. Clinical recurrence was not related to the age of the patient at onset, duration, or severity of disease. Recurrence was related to the electron microscopic findings of myofibroblasts in the nodules and fibroblasts containing prominent microtubules in the fascia of these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7364813

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  9 in total

Review 1.  Dupuytren's disease.

Authors:  S M Gonzalez; R I Gonzalez
Journal:  West J Med       Date:  1990-04

2.  Update on the role of molecular factors and fibroblasts in the pathogenesis of Dupuytren's disease.

Authors:  Massimiliano Tripoli; Adriana Cordova; Francesco Moschella
Journal:  J Cell Commun Signal       Date:  2016-06-07       Impact factor: 5.782

3.  Cytogenetic studies in Dupuytren contracture.

Authors:  D H Wurster-Hill; F Brown; J P Park; S H Gibson
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

Review 4.  Contraction and the control of contraction.

Authors:  R Rudolph
Journal:  World J Surg       Date:  1980-05       Impact factor: 3.352

5.  Examining the efficacy and maintenance of contracture correction after collagenase clostridium histolyticum treatment for Dupuytren's disease.

Authors:  Heather A McMahon; Abdo Bachoura; Sidney M Jacoby; David S Zelouf; Randall W Culp; A Lee Osterman
Journal:  Hand (N Y)       Date:  2013-09

6.  Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.

Authors:  Latha Satish; Phillip H Gallo; Mark E Baratz; Sandra Johnson; Sandeep Kathju
Journal:  BMC Musculoskelet Disord       Date:  2011-05-25       Impact factor: 2.362

7.  Dupuytren's Disease: Review of the Current Literature.

Authors:  Morsi Khashan; Peter J Smitham; Wasim S Khan; Nicholas J Goddard
Journal:  Open Orthop J       Date:  2011-07-28

Review 8.  Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances.

Authors:  David Warwick; José M Arandes-Renú; Giorgio Pajardi; Jörg Witthaut; Lawrence C Hurst
Journal:  J Plast Surg Hand Surg       Date:  2016-04-06

9.  Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2.

Authors:  Raymond Tse; Jeffrey Howard; Yan Wu; Bing Siang Gan
Journal:  BMC Musculoskelet Disord       Date:  2004-11-12       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.